RetinalGenix Technologies Inc.
RTGN
RetinalGenix Technologies Inc. ( RetinalGenix or the Company ) is an ophthalmic research and development company focused on developing technologies to screen, provide information and treat eye health disorders (ophthalmic, optical, and sight-threatening disorders), Our devices described below are designed to facilitate the early detection of such diseases and empowering patients and their clini…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$2M
▲ +43.8% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$457K
▲ +24.7% YoY
Net Debt
$104K
Cash & Equiv.
$5.00
Continue Research
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RTGN
RetinalGenix Technologies (RTGN) in two numbers
Questions about RetinalGenix Technologies
Does RetinalGenix Technologies (RTGN) pay a dividend?
No. RetinalGenix Technologies (RTGN) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 16 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in RTGN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing RTGN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.